HUP0002324A2 - Benzimidazolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents

Benzimidazolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0002324A2
HUP0002324A2 HU0002324A HUP0002324A HUP0002324A2 HU P0002324 A2 HUP0002324 A2 HU P0002324A2 HU 0002324 A HU0002324 A HU 0002324A HU P0002324 A HUP0002324 A HU P0002324A HU P0002324 A2 HUP0002324 A2 HU P0002324A2
Authority
HU
Hungary
Prior art keywords
group
alkyl
aralkyl
alkenyl
alkoxy
Prior art date
Application number
HU0002324A
Other languages
English (en)
Inventor
Takahiro Hiramura
Takafumi Imoto
Akira Katayama
Hiroshi Kayakiri
Masahiro Nishikawa
Teruo Oku
Osamu Onomura
Hitoshi Sawada
Noritsugu Yamasaki
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of HUP0002324A2 publication Critical patent/HUP0002324A2/hu
Publication of HUP0002324A3 publication Critical patent/HUP0002324A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

A találmány szerinti új vegyületek (n) általánosképletében R1 jelentése hidrogénatom, alkilcsoport, alkoxicsoport vagyalkil-tio-csoport, R2 jelentése aralkil- vagy heteroaralkil csoport,amely adott esetben, egy vagy több halogénatom, alkilcsoport, halogén-alkil-csoport, nitrocsoport, alkoxi-karbonil-csoport, aromás csoport,aralkil-oxi-csoport, cikloalkil-oxi-alkil-csoport, aralkilcsoport,aralkenilcsoport, aralkinilcsoport, aromás-oxi-alkilcsoport,cikloalkil-alkil-oxi-csoport, alkenilcsoport, alkoxi-csoport, alkil-tio-csoport, alkán-szulfinil-csoport, alkán-szulfonil-csoport ésalkán-szulfonil-karbamoil-csoport közül megválasztott szubsztituensselszubsztituálva lehet, R3 jelentése alkilcsoport, hidroxi-alkil-csoport, alkenilcsoport, aromás csoport, halogénezett aromás csoport,alkil-aril-csoport, alkenil-aril-csoport, aralkilcsoport vagyaralkenilcsoport, -X- jelentése (II)-(VI) képletű csoport. A találmánykiterjed a fenti vegyületeket tartalmazó gyógyszerkészítményekre,amelyek a vér cukorszintjét csökkentő vagy PDE5 inhibitor hatássalrendelkeznek. Ó
HU0002324A 1997-06-27 1998-06-26 Benzimidazole derivatives and pharmaceutical compositions containing them HUP0002324A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18769697 1997-06-27
JP7635798 1998-03-25
PCT/JP1998/002885 WO1999000373A1 (fr) 1997-06-27 1998-06-26 Derives de benzimidazole

Publications (2)

Publication Number Publication Date
HUP0002324A2 true HUP0002324A2 (hu) 2001-05-28
HUP0002324A3 HUP0002324A3 (en) 2001-07-30

Family

ID=26417500

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002324A HUP0002324A3 (en) 1997-06-27 1998-06-26 Benzimidazole derivatives and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US6420409B1 (hu)
EP (1) EP1020452A4 (hu)
KR (1) KR20010014166A (hu)
CN (1) CN1135224C (hu)
AR (1) AR016108A1 (hu)
AU (1) AU748541B2 (hu)
BR (1) BR9811273A (hu)
CA (1) CA2294505A1 (hu)
HK (1) HK1028246A1 (hu)
HU (1) HUP0002324A3 (hu)
IL (1) IL133674A0 (hu)
RU (1) RU2243968C2 (hu)
TR (1) TR199903277T2 (hu)
TW (1) TW453999B (hu)
WO (1) WO1999000373A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2295239A1 (en) * 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
WO1999051574A1 (fr) * 1998-04-06 1999-10-14 Fujisawa Pharmaceutical Co., Ltd. Derives d'indole
WO2000028991A1 (fr) * 1998-11-13 2000-05-25 Fujisawa Pharmaceutical Co., Ltd. Remedes contre le syndrome des ovaires polykystiques
WO2000039099A1 (fr) * 1998-12-24 2000-07-06 Fujisawa Pharmaceutical Co., Ltd. Derives de benzimidazole
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
US6525067B1 (en) 1999-11-23 2003-02-25 Pfizer Inc Substituted heterocyclic derivatives
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
EP1442042A1 (en) 2001-11-09 2004-08-04 Schering Corporation Polycyclic guanine derivative phosphodiesterase v inhibitors
US20050032854A1 (en) * 2001-12-03 2005-02-10 Kiminori Kawahara Insulin resistance improving agents
US20030181461A1 (en) * 2002-01-25 2003-09-25 Lautt Wilfred Wayne Use of phosphodiesterase antagonists to treat insulin resistance
AU2003223093B2 (en) * 2002-05-03 2010-02-04 Israel Institute For Biological Research Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
AU2003902860A0 (en) * 2003-06-06 2003-06-26 Daicel Chemical Industries, Ltd Benzimidazole compounds
US20050197376A1 (en) * 2004-03-02 2005-09-08 Fujisawa Pharmaceutical Co. Ltd. Concomitant drugs
EP1983992A4 (en) * 2006-01-19 2010-08-18 Abbott Lab 2-IMINO-BENZIMIDAZOLES
WO2011063339A1 (en) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
CN105919987B (zh) * 2009-12-07 2020-04-03 约翰斯霍普金斯大学 N-酰氧基磺酰胺和n-羟基-n-酰基磺酰胺衍生物及其用途
CA2782248A1 (en) 2009-12-07 2011-06-16 Cardioxyl Pharmaceuticals, Inc. Bis-acylated hydroxylamine derivatives
JP5990106B2 (ja) * 2011-01-28 2016-09-07 佐藤製薬株式会社 縮環化合物
JP6456520B2 (ja) 2015-12-11 2019-01-23 帝人ファーマ株式会社 アミノアゾール誘導体
WO2017192728A1 (en) 2016-05-03 2017-11-09 Virginia Commonwealth University Heteroatom -doped porous carbons for clean energy applications and methods for their synthesis

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE676196C (de) 1936-08-21 1939-05-30 I G Farbenindustrie Akt Ges Verfahren zur Herstellung von Imidazolverbindungen
US3152142A (en) 1962-05-24 1964-10-06 Dow Chemical Co Benzimidazole compounds
FR2291749A1 (fr) 1974-11-20 1976-06-18 Delalande Sa Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique
JPS51133267A (en) 1975-05-08 1976-11-18 Lilly Co Eli Substituted 11sulphonyl benzimidazole
US4179505A (en) 1977-03-30 1979-12-18 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
US4243806A (en) 1979-06-13 1981-01-06 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
GB2053215B (en) 1979-06-25 1983-04-07 May & Baker Ltd Benzimidazole derivatives
JPS625966A (ja) 1985-07-03 1987-01-12 Nippon Shinyaku Co Ltd ベンズイミダゾ−ル誘導体
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
CA2004911A1 (en) 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
WO1991016313A1 (en) 1990-04-13 1991-10-31 Smithkline Beecham Corporation Substituted benzimidazoles
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5703110A (en) 1990-04-27 1997-12-30 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
RU1836357C (ru) 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
DE4023369A1 (de) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5602127A (en) 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5594003A (en) 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5591762A (en) 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
US5407835A (en) 1991-07-31 1995-04-18 Abbott Laboratories Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids
GB9121776D0 (en) 1991-10-14 1991-11-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives and process for preparation thereof
DE4237557A1 (de) 1992-11-06 1994-05-11 Bayer Ag Substituierte Benzimidazole
JPH0853424A (ja) 1994-08-11 1996-02-27 Kureha Chem Ind Co Ltd ベンズイミダゾールスルホン酸アミド誘導体
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
EP0882718B1 (en) * 1995-12-28 2005-08-31 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives

Also Published As

Publication number Publication date
CN1135224C (zh) 2004-01-21
HUP0002324A3 (en) 2001-07-30
AU7934698A (en) 1999-01-19
RU2243968C2 (ru) 2005-01-10
CA2294505A1 (en) 1999-01-07
HK1028246A1 (en) 2001-02-09
EP1020452A4 (en) 2003-04-02
WO1999000373A1 (fr) 1999-01-07
TW453999B (en) 2001-09-11
US6420409B1 (en) 2002-07-16
WO1999000373A8 (fr) 2000-07-20
AU748541B2 (en) 2002-06-06
AR016108A1 (es) 2001-06-20
BR9811273A (pt) 2000-07-18
CN1268123A (zh) 2000-09-27
KR20010014166A (ko) 2001-02-26
IL133674A0 (en) 2001-04-30
TR199903277T2 (xx) 2000-07-21
EP1020452A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
HUP0002324A2 (hu) Benzimidazolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
FI935529A (fi) Aminometylensubstituerade icke-aromatiska heterocykliska foereningar
HUP0002483A2 (hu) CETP aktivítást gátló vegyületek
NO308736B1 (no) 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse
DK459086D0 (da) Quinazolinderivater
NO953305D0 (no) Antranilsyrederivat
DK1023308T3 (da) Inhibitorer af nukleosidmetabolisme
HUP0103413A2 (hu) Heterociklusos származékok mint rotamáz-enzimek inhibitorai, köztitermékei, eljárás ezek előállítására, és ezeket tartalmazó gyógyszerkészítmények
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
HUP0402235A2 (hu) 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények
HUP0002239A2 (hu) Tieno-pirimidin-származékok alkalmazása gombák leküzdésére
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
HUP0203487A2 (hu) Tetrahidrotiopirán-ftalazinon-származékok, mint PDE4-inhibitorok és ezeket tartalmazó gyógyszerkészítmények
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
ES2001106A6 (es) Procedimiento para la obtencion de 1-aril-pirazoles
HUP0203478A2 (hu) Új tiazolidin-dion-származékok, mint antidiabéteszes szerek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
IL115084A (en) Carbamoylcarboxamides fungicidal compositions containing them and their preparation
ATE191465T1 (de) Carbamoylcarbonsäureamide
BR0211180A (pt) Compostos, processo para preparar os mesmos, intermediários, e, composição adequada e método para controlar fungos fitopatogênicos
DE69228877D1 (de) Benzoaxole,benzothiazol und benzimidazol derivate als fungizide
ATE106891T1 (de) 2'-deoxy-5-fluorouridin-derivate.
DK562783A (da) Pyrrolidinderivater og deres fremstilling samt laegemidler indeholdende saadanne derivater
EE9900238A (et) Difenüülalküültetrahüdropüridiinid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon
NO985298D0 (no) Polyhydroksyfenolderivater og preventive og terapeutiske midler for ben- og brusksykdommer inneholdende disse
HUP0302263A2 (hu) Higromicinszármazékok és ezeket tartalmazó gyógyászati készítmények bakteriális és protozoon fertőzések kezelésére

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees